19
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 22291.
Regulatory Information RX
With a dosage strength EQ 75MG ACID
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2009-09-08
18
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 22291.
Regulatory Information RX
With a dosage strength EQ 25MG ACID
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2008-11-20
17
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 22291.
Regulatory Information RX
With a dosage strength EQ 12.5MG ACID
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2011-10-20
16
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 22291.
Regulatory Information RX
With a dosage strength EQ 50MG ACID
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2008-11-20
15
Novartis Pharmaceuticals Corporation, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELTROMBOPAG OLAMINE, with a corresponding application number 22291.
Regulatory Information DISCN
With a dosage strength EQ 100MG ACID **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug Yes
Approved since 2012-11-16